80 related articles for article (PubMed ID: 20624122)
1. Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity.
Li JL; Jubb AM; Harris AL
Future Oncol; 2010 Jul; 6(7):1099-103. PubMed ID: 20624122
[TBL] [Abstract][Full Text] [Related]
2. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
3. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
4. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis.
Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A
Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447
[TBL] [Abstract][Full Text] [Related]
5. Delta-like 4/Notch signaling and its therapeutic implications.
Yan M; Plowman GD
Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
[TBL] [Abstract][Full Text] [Related]
6. PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.
Iwamoto H; Zhang Y; Seki T; Yang Y; Nakamura M; Wang J; Yang X; Torimura T; Cao Y
Sci Adv; 2015 Apr; 1(3):e1400244. PubMed ID: 26601163
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma.
Haller BK; Bråve A; Wallgard E; Roswall P; Sunkari VG; Mattson U; Hallengärd D; Catrina SB; Hellström M; Pietras K
Oncogene; 2010 Jul; 29(30):4276-86. PubMed ID: 20498640
[TBL] [Abstract][Full Text] [Related]
8. The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy?
Brzozowa M; Wojnicz R; Kowalczyk-Ziomek G; Helewski K
Contemp Oncol (Pozn); 2013; 17(3):234-7. PubMed ID: 24596507
[TBL] [Abstract][Full Text] [Related]
9. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis.
Kuhnert F; Kirshner JR; Thurston G
Vasc Cell; 2011 Sep; 3(1):20. PubMed ID: 21923938
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M
Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
[TBL] [Abstract][Full Text] [Related]
12. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
Oon CE; Harris AL
Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
[TBL] [Abstract][Full Text] [Related]
13. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells.
Estrach S; Cailleteau L; Franco CA; Gerhardt H; Stefani C; Lemichez E; Gagnoux-Palacios L; Meneguzzi G; Mettouchi A
Circ Res; 2011 Jul; 109(2):172-82. PubMed ID: 21474814
[TBL] [Abstract][Full Text] [Related]
14. [Influence of Delta-like ligand 4/Notch signal transduction pathway upon the biological behavior of human umbilical vein endothelial cells].
Chen L; Lü W; Wei B; Wang N; Li T
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3106-10. PubMed ID: 20193271
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
16. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching.
Suchting S; Freitas C; le Noble F; Benedito R; Bréant C; Duarte A; Eichmann A
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3225-30. PubMed ID: 17296941
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
Novartis Found Symp; 2007; 283():106-20; discussion 121-5, 238-41. PubMed ID: 18300417
[TBL] [Abstract][Full Text] [Related]
19. Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2-driven luteal angiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells.
García-Pascual CM; Zimmermann RC; Ferrero H; Shawber CJ; Kitajewski J; Simón C; Pellicer A; Gómez R
Fertil Steril; 2013 Dec; 100(6):1768-76.e1. PubMed ID: 24074756
[TBL] [Abstract][Full Text] [Related]
20. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.
Lobov IB; Renard RA; Papadopoulos N; Gale NW; Thurston G; Yancopoulos GD; Wiegand SJ
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3219-24. PubMed ID: 17296940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
